Thomson Reuters Scholarone Journal Triathlon Winner Q&A
Congratulations to Thrombosis and Haemostasis, winner of the inaugural ScholarOne Journal Triathlon!
The ScholarOne Journal Triathlon is a global, virtual tournament designed to have journals compete in three categories: agility, speed and endurance, attributes essential for successful publications. The competition is comprised of the following events to honor the scholarly community's most innovative journals:
- Swim (Agility): the ability of a journal to validate it is accepting the right papers
- Bike (Speed): how quickly a journal implements ways to increase its efficiency
- Run (Endurance): the longevity of a journal and how it seamlessly adapts its processes to stay competitive in an ever-changing industry
The top three journals receiving the most public votes in each leg of the competition advanced to the finals to compete for the coveted spot of Journal Triathlon Champion, determined by a panel of Thomson Reuters judges. Read on to find out how winning journal Thrombosis and Haemostasis is implementing innovative strategies to enhance the publishing process.
Interview With Elinor Switzer
Our journal Thrombosis and Haemostasis has been a leader in its field of haematology and vascular biology since its founding in 1957. In 2002 the publisher decided that it was time to start using an online submission system. Thus we started to set up a submission site with ScholarOne Manuscript Central. When we chose the workflow, we initially had one Editor in Chief and an Editorial Board of about 40 Section Editors. In 2008 we then started having a double Editor-in-Chief team to match the demand for expertise in both the basic science and the clinical areas. Thus we adjusted our Manuscript Central system accordingly, and are now very happy with the smooth workflow. The Managing Editor has been the same over the past eight years, so there has been a continuity which has helped everyone involved.
Our peer-reviewed journal Thrombosis and Haemostasis provides efficient and timely review of submitted manuscripts through its streamlined workflow. The two Editors in Chief, one each for basic science and for clinical studies, as well as the dedicated Editorial Board of now more than 50 Section Editors, invite expert reviewers, assess papers for their technical merit, originality, and the degree to which they further advance the field. Thrombosis and Haemostasis provides efficient and timely review of submitted manuscripts with a time from submission to first decision of 22 days. This is achieved with the aid of features in Manuscript Central such as automatic referee invite and automated reminders. Furthermore, the dedicated editorial staff responds to author or referee queries personally and very quickly (often within minutes) and is always there to help. The steadily increasing Impact Factor of Thrombosis and Haemostasis over the past decade (Impact Factor 2012: 6.094) is proof that we are making the right choices.
We started using ScholarOne Manuscript Central over 10 years ago, and 2013 was an especially exciting year with Thrombosis and Haemostasis passing the mark of 1,000 submissions for the first time. With the help of Manuscript Central we have been able to manage this increasing workload with just one Managing Editor who is administrator, copy editor and editorial office staff, all in one person, as well as a very helpful editorial assistant who assists the two Editors in Chief and the Section Editors. In these past ten years we have also started using Manuscript Central for six further journals in our publishing house.
Our successful participation in the ScholarOne Journal Triathlon is further proof (and reward) to us that our efforts in implementing and adjusting the Manuscript Central workflow to the constantly changing needs and demands of Section Editors, reviewers and authors are recognized. Also, we are grateful to our supporters who voted for Thrombosis and Haemostasis in the Journal Triathlon and thus showed us how much they value the work we do.
The data and citation records included in this report are from Thomson Reuters Web of ScienceTM. Web of ScienceTM is a registered trademark of Thomson Reuters. All rights reserved.